Home » Clinical Trials » Inherited retinal dystrophy » NCT06048185
NCT06048185

Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT Study

Study Summary

The current study is a non-interventional long-term safety follow-up of the subjects who completed STARLIGHT, in accordance with FDA guidance on recipients of human gene therapy products.

Interested in this trial?

Submit an Inquiry

Interventions

Gene Therapy Product-MCO-010BIOLOGICAL
The MCO-010 is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette

Study Locations

FacilityCityStateCountry
Nanocope Clnical SiteMiamiFloridaUnited States
Nanoscope Clinical SiteMcAllenTexasUnited States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026